Charlie's Holdings, INC

Charlie's Holdings, Inc. announced the immediate appointment of Henry Sicignano III as CEO and Ryan Stump's transition to focus on strategic partnerships, alongside plans to launch age-gated flavored disposable vapes.

Charlie's Holdings stockholders approved a reverse stock split and an increase in equity incentive plan shares.

Charlie's Holdings, Inc. completed a private placement of common stock, raising $710,000 for working capital and PMTA amendments.

Charlie's Holdings, Inc. sold an additional PACHA synthetic product and related asset to R. J. Reynolds Vapor Company for $1.0 million, bringing the total purchased to sixteen.

Charlie's Holdings, Inc. has amended its Asset Purchase Agreement with R. J. Reynolds Vapor Company, selling three more PACHA synthetic products and related assets for $1.5 million, bringing the total products sold to fifteen.

Charlie's Holdings, Inc. has completed the sale of its PACHA synthetic product assets to R. J. Reynolds Vapor Company for $5 million upfront, with a potential additional $4.2 million contingent payment.

Charlies Holdings, Inc. reported a significant increase in revenue for the first quarter of 2026, driven by strong sales in its nicotine-based and alternative alkaloid products, despite an overall net loss.

Charlies Holdings, Inc. reported a significant net income for Q3 2025, driven by a $7.5 million asset sale and strong early sales of its new SBX Metatine vape products, despite ongoing regulatory challenges and a 'going concern' warning.

Charlies Holdings, Inc. reported a significant net income for Q2 2025, driven by a $6.5 million asset sale, substantially improving its liquidity and working capital despite ongoing operational losses.

Charlie's Holdings, a producer of nicotine and alternative vapor products, reported a 24.4% revenue decrease and increased net loss for Q1 2025, but significantly improved its financial position through a $6.5 million asset sale to R.J. Reynolds Vapor Company post-period, addressing going concern doubts.

Charlies Holdings experienced a significant revenue decline in Q3 2024, alongside increased net losses and working capital deficits, while navigating a complex regulatory landscape.

Charlies Holdings experienced a significant revenue decline and net loss in Q2 2024, while navigating a complex regulatory landscape and ongoing concerns about its ability to continue as a going concern.

Charlies Holdings, Inc. faced a challenging 2024, reporting a significant 47.7% drop in revenue and a near doubling of its net loss, raising substantial doubt about its ability to continue as a going concern, despite strategic shifts towards non-nicotine products and ongoing regulatory compliance efforts.

Charlies Holdings, Inc. reports a decrease in revenue for 2023, alongside ongoing regulatory hurdles and concerns about its ability to continue as a going concern.

Charlie's Holdings, Inc. Chief Operating Officer Ryan Stump acquired 250,000 shares of common stock at $0.20 per share, increasing his direct beneficial ownership.

Charlie's Holdings, Inc. President Henry Sicignano III has filed a Form 4 indicating a planned future purchase of 250,000 shares of common stock at $0.20 per share on February 13, 2026.

Charlie's Holdings CFO Matthew P. Montesano acquired 100,000 shares of common stock at $0.20 per share, increasing his direct beneficial ownership.

Charlie's Holdings Director Michael D. King plans to acquire 500,000 shares of common stock at $0.20 per share on February 13, 2026, increasing his beneficial ownership to over 6.7 million shares.

Edward Carmines, a Director at Charlie's Holdings, Inc., purchased 250,000 shares of common stock for $0.20 per share.

Edward Carmines, a Director at Charlie's Holdings, Inc., acquired 100,000 shares of common stock for approximately $27,600 through a pre-arranged trading plan.

Charlie's Holdings, Inc. seeks shareholder approval for a reverse stock split and an increase in equity incentive plan shares to facilitate a potential national exchange uplisting.

Charlies Holdings, Inc. has announced its 2025 Annual Meeting of Stockholders to address director elections and auditor ratification, while revealing increasing net losses and continued reliance on high-interest related-party debt with extended maturity dates.

Charlies Holdings, Inc. has announced its 2025 Annual Meeting agenda, highlighting the election of directors and auditor ratification, while disclosing significant executive compensation reductions, increasing net losses, and continued reliance on high-interest related-party financing with multiple maturity extensions.

Charlie's Holdings is asking stockholders to approve a reverse stock split to potentially meet listing requirements for a national securities exchange.

An amendment to a Schedule 13G filing reveals that Iroquois Capital Management L.L.C. and its affiliated entities, including Richard Abbe, have reduced their aggregate beneficial ownership in Charlie's Holdings, Inc. to 4.8% of outstanding common stock.